list of glp-1 receptor agonist glp 1 agonists brand names Understanding Agonists: Key Insights for Payers The GLP-1 Agonists and Obesity:
Description
While GIP indeed acts as an incretin in healthy individuals, researchers found an important limitation in patients with type 2 diabetes, GIP loses most of its insulinotropic efficacy (the pancreatic cells become GIP-resistant) ( [32] )

226.Kendrick K.N., Bode Padron K.J., Bomani N.Z., German J.C., Nyanyo D.D., Varriano B., Tu L., Stanford F.C

But it almost certainly reduces the gastrointestinal rebound effects that some researchers report after abrupt cessation, including paradoxical increases in appetite, changes in bowel habits, and blood sugar fluctuations

It suppresses release of glucagon , a hormone that signals the liver to send the glucose it contains into circulation

A BMI of 27 or higher contributes to high blood pressure, cholesterol, or sleep apnea
